Literature DB >> 18439910

Induction of neural stem cell-like cells (NSCLCs) from mouse astrocytes by Bmi1.

Jai-Hee Moon1, Byung Sun Yoon, Bona Kim, Gyuman Park, Hye-Youn Jung, Isaac Maeng, Eun Kyoung Jun, Seung Jun Yoo, Aeree Kim, Sejong Oh, Kwang Youn Whang, Hyunggee Kim, Dong-Wook Kim, Ki Dong Kim, Seungkwon You.   

Abstract

Recently, Bmi1 was shown to control the proliferation and self-renewal of neural stem cells (NSCs). In this study, we demonstrated the induction of NSC-like cells (NSCLCs) from mouse astrocytes by Bmi1 under NSC culture conditions. These NSCLCs exhibited the morphology and growth properties of NSCs, and expressed NSC marker genes, including nestin, CD133, and Sox2. In vitro differentiation of NSCLCs resulted in differentiated cell populations containing astrocytes, neurons, and oligodendrocytes. Following treatment with histone deacetylase inhibitors (trichostatin A and valproic acid), the potential of NSCLCs for proliferation, dedifferentiation, and self-renewal was significantly inhibited. Our data indicate that multipotent NSCLCs can be generated directly from astrocytes by the addition of Bmi1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439910     DOI: 10.1016/j.bbrc.2008.04.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Transcription factors and neural stem cell self-renewal, growth and differentiation.

Authors:  Sohail Ahmed; Hui Theng Gan; Chen Sok Lam; Anuradha Poonepalli; Srinivas Ramasamy; Yvonne Tay; Muly Tham; Yuan Hong Yu
Journal:  Cell Adh Migr       Date:  2009-10-27       Impact factor: 3.405

2.  Off-target effect of the BMI1 inhibitor PTC596 drives epithelial-mesenchymal transition in glioblastoma multiforme.

Authors:  Anthony Flamier; Mohamed Abdouh; Rimi Hamam; Andrea Barabino; Niraj Patel; Andy Gao; Roy Hanna; Gilbert Bernier
Journal:  NPJ Precis Oncol       Date:  2020-01-06

3.  Reactivated astrocytes as a possible source of oligodendrocyte precursors for remyelination in remitting phase of experimental autoimmune encephalomyelitis rats.

Authors:  An-Chen Guo; Takho Chu; Xu-Qing Liu; Huan-Xing Su; Wu-Tian Wu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Timing of the cell cycle exit of differentiating hippocampal neural stem cells.

Authors:  Elina Järvinen; Alexandre Angers-Loustau; Ana-Maria Osiceanu; Kirmo Wartiovaara
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

Review 5.  Genetically engineered mouse models in cancer research.

Authors:  Jessica C Walrath; Jessica J Hawes; Terry Van Dyke; Karlyne M Reilly
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

Review 6.  Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques.

Authors:  Hao Yang; Cui-Cui Liu; Chun-Yu Wang; Qian Zhang; Jiang An; Lingling Zhang; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2015-04-12       Impact factor: 5.590

7.  Reprogrammed mouse astrocytes retain a "memory" of tissue origin and possess more tendencies for neuronal differentiation than reprogrammed mouse embryonic fibroblasts.

Authors:  Changhai Tian; Yongxiang Wang; Lijun Sun; Kangmu Ma; Jialin C Zheng
Journal:  Protein Cell       Date:  2011-03-05       Impact factor: 14.870

8.  Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors.

Authors:  C Tian; R J Ambroz; L Sun; Y Wang; K Ma; Q Chen; B Zhu; J C Zheng
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

9.  Identification of a polymorphism in the RING finger of human Bmi-1 that causes its degradation by the ubiquitin-proteasome system.

Authors:  Jie Zhang; Kevin D Sarge
Journal:  FEBS Lett       Date:  2009-02-20       Impact factor: 4.124

10.  Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells.

Authors:  Min Hua Luo; Holger Hannemann; Amit S Kulkarni; Philip H Schwartz; John M O'Dowd; Elizabeth A Fortunato
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.